You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 8, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Jennifer Patino-Alonso1, Justo Cabrera-González1,2, Javier Merino1
1Departamento de Química Orgánica, Facultad de Química, Universidad Complutense, Madrid, E-28040, Spain.
Researchers developed novel nanostructures to block DC-SIGN, an important receptor for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. These glycomimetics achieved up to 90% inhibition of viral trans-infection, offering a promising therapeutic strategy.
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: